Intravenous iron isomaltoside 1000 (Monofer®) reduces postoperative anaemia in preoperatively non-anaemic patients undergoing elective or subacute coronary artery bypass graft, valve replacement or a combination thereof: a randomized double-blind placebo-controlled clinical trial (the PROTECT trial)

BACKGROUND AND OBJECTIVES: This trial explores whether intravenous iron isomaltoside 1000 (Monofer®) results in a better regeneration of haemoglobin levels and prevents anaemia compared to placebo in preoperative non-anaemic patients undergoing cardiac surgery. STUDY DESIGN AND METHODS: The trial is...

Descripción completa

Detalles Bibliográficos
Autores principales: Johansson, P I, Rasmussen, A S, Thomsen, L L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Ltd 2015
Materias:
Transfusion Medicine and New Therapies
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690506/
https://www.ncbi.nlm.nih.gov/pubmed/25900643
http://dx.doi.org/10.1111/vox.12278

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4690506/
https://www.ncbi.nlm.nih.gov/pubmed/25900643
http://dx.doi.org/10.1111/vox.12278

Ejemplares similares